Literature DB >> 35549399

New subvariants are masters of immune evasion.

Gretchen Vogel.   

Abstract

Vaccines and prior infection still prevent severe disease from new SARS-CoV-2 strains.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35549399     DOI： 10.1126/science.adc9448

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   63.714


  4 in total

Review 1.  Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.

Authors:  Shuai Xia; Lijue Wang; Yun Zhu; Lu Lu; Shibo Jiang
Journal:  Signal Transduct Target Ther       Date:  2022-07-19

2.  Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence.

Authors:  Zhongtian Qi; Jianbo Wu; Shibo Jiang
Journal:  Clin Transl Med       Date:  2022-06

3.  Developing evolution-resistant drugs for COVID-19.

Authors:  Daniel M Weinreich
Journal:  Elife       Date:  2022-07-26       Impact factor: 8.713

4.  Wastewater monitoring comes of age.

Authors: 
Journal:  Nat Microbiol       Date:  2022-08       Impact factor: 30.964
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.